Company Quick10K Filing
Lexaria Bioscience
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 81 $70
10-Q 2020-01-09 Quarter: 2019-11-30
10-K 2019-11-14 Annual: 2019-08-31
10-Q 2019-07-08 Quarter: 2019-05-31
10-Q 2019-04-15 Quarter: 2019-02-28
10-Q 2019-01-11 Quarter: 2018-11-30
10-K 2018-11-14 Annual: 2018-08-31
10-Q 2018-07-13 Quarter: 2018-05-31
10-Q 2018-04-12 Quarter: 2018-02-28
10-Q 2018-01-12 Quarter: 2017-11-30
10-K 2017-11-27 Annual: 2017-08-31
10-Q 2017-07-14 Quarter: 2017-05-31
10-Q 2017-04-14 Quarter: 2017-02-28
10-Q 2017-01-13 Quarter: 2016-11-30
10-K 2016-11-29 Annual: 2016-08-31
10-Q 2016-07-13 Quarter: 2016-05-31
10-Q 2016-04-13 Quarter: 2016-02-29
10-Q 2016-01-08 Quarter: 2015-11-30
10-K 2015-11-27 Annual: 2015-08-31
10-Q 2015-07-14 Quarter: 2015-05-31
10-Q 2015-04-14 Quarter: 2015-02-28
10-Q 2015-01-14 Quarter: 2014-11-30
10-Q 2014-09-11 Quarter: 2014-07-31
10-Q 2014-06-12 Quarter: 2014-04-30
10-Q 2014-03-12 Quarter: 2014-01-31
10-K 2014-01-24 Annual: 2013-10-31
10-Q 2013-09-10 Quarter: 2013-07-31
10-Q 2013-06-12 Quarter: 2013-04-30
10-Q 2013-03-13 Quarter: 2013-01-31
10-K 2013-01-29 Annual: 2012-10-31
10-Q 2012-09-12 Quarter: 2012-07-31
10-Q 2012-06-07 Quarter: 2012-04-30
10-Q 2012-03-13 Quarter: 2012-01-31
10-K 2012-01-30 Annual: 2011-10-31
10-Q 2011-09-14 Quarter: 2011-07-31
10-Q 2011-06-13 Quarter: 2011-04-30
10-Q 2011-03-15 Quarter: 2011-01-31
10-K 2011-01-31 Annual: 2010-10-31
10-Q 2010-09-07 Quarter: 2010-07-31
10-Q 2010-06-01 Quarter: 2010-04-30
10-Q 2010-03-15 Quarter: 2010-01-31
10-K 2010-01-20 Annual: 2009-10-31
8-K 2020-01-14 Regulation FD
8-K 2020-01-09 Regulation FD, Exhibits
8-K 2019-11-28 Sale of Shares, Exhibits
8-K 2019-11-13 Sale of Shares, Exhibits
8-K 2019-08-27 Regulation FD
8-K 2019-08-14 Officers, Regulation FD
8-K 2019-08-01 Regulation FD
8-K 2019-07-23 Enter Agreement, Exhibits
8-K 2019-07-11 Enter Agreement, Regulation FD, Exhibits
8-K 2019-06-20 Shareholder Vote
8-K 2019-06-04 Regulation FD, Exhibits
8-K 2019-05-15 Enter Agreement, Other Events
8-K 2019-04-29 Other Events, Exhibits
8-K 2019-04-15 Other Events, Exhibits
8-K 2019-04-05 Officers, Other Events, Exhibits
8-K 2019-03-20 Leave Agreement
8-K 2019-01-28 Sale of Shares, Regulation FD, Exhibits
8-K 2019-01-15 Enter Agreement, Exhibits
8-K 2019-01-15 Regulation FD, Exhibits
8-K 2018-12-14 Sale of Shares, Regulation FD, Exhibits
8-K 2018-12-07 Sale of Shares, Regulation FD, Exhibits
8-K 2018-11-26 Sale of Shares, Regulation FD, Exhibits
8-K 2018-11-13 Regulation FD, Exhibits
8-K 2018-10-31 Sale of Shares, Regulation FD, Exhibits
8-K 2018-10-16 Regulation FD, Exhibits
8-K 2018-10-10 Sale of Shares, Regulation FD, Exhibits
8-K 2018-09-07 Regulation FD, Exhibits
8-K 2018-08-30 Sale of Shares, Regulation FD, Exhibits
8-K 2018-08-07 Sale of Shares, Regulation FD, Exhibits
8-K 2018-07-31 Enter Agreement, Regulation FD, Exhibits
8-K 2018-07-03 Shareholder Vote, Regulation FD, Exhibits
8-K 2018-06-29 Regulation FD, Exhibits
8-K 2018-06-20 Sale of Shares, Regulation FD, Exhibits
8-K 2018-05-28 Enter Agreement, Sale of Shares, Regulation FD, Exhibits
8-K 2018-05-23 Sale of Shares, Regulation FD, Exhibits
8-K 2018-04-27 Enter Agreement, Regulation FD, Exhibits
8-K 2018-04-25 Enter Agreement, Regulation FD, Exhibits
8-K 2018-04-17 Regulation FD, Exhibits
8-K 2018-04-11 Regulation FD, Exhibits
8-K 2018-03-23 Sale of Shares, Regulation FD, Exhibits
8-K 2018-03-20 Regulation FD
8-K 2018-03-13 Regulation FD, Exhibits
8-K 2018-02-27 Enter Agreement, Regulation FD
8-K 2018-02-02 Sale of Shares, Regulation FD, Exhibits
8-K 2018-01-25 Enter Agreement, Regulation FD, Exhibits
8-K 2018-01-17 Sale of Shares, Regulation FD, Exhibits
8-K 2018-01-08 Sale of Shares, Regulation FD, Exhibits

Lexaria Bioscience Financials

LXRP Metrics, Comps, Filings

Annual | Quarterly

Business

Our audited annual consolidated financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP). The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this report.

In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars. All references to "C$" or "CDN$" refer to Canadian dollars and all references to "common shares" and "shares" refer to the common shares in our capital stock, unless otherwise indicated.

As used in this quarterly report, the terms "Lexaria" "we", "us", "our" and "Company" mean Company and/or our subsidiaries, unless otherwise indicated.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Corning Natural Gas (CNIG) 73,160 66% 10.6 3% 113,110 50,089 37,813 24,848 3,320 10,667 112,584
Carbon Energy (CRBO) 72,298 94% 2.6 2% 304,547 227,586 78,716 73,817 7,324 26,452 67,647
I-AM Capital Acquisition (IAMXU) 71,791 0% -22.9 -40% 7,755 1,887 14 0 -3,065 -3,065 70,251
QS Energy (QSEP) 71,630 -13.5 -549% 973 2,497 0 0 -5,341 -5,331 72,143
Senomyx (SNMX) 71,057 0% 0% 21,391 7,333 26,377 0 0 0 56,357
Anchor Bancorp (ANCB) 70,950 6.8 1% 478,880 410,204 0 0 2,434 10,456 70,950
RLJ Entertainment (RLJE) 70,946 46% -36.9 -5% 146,899 136,071 93,640 42,654 -7,438 -3,316 122,300
Super League Gaming (SLGG) 70,616 60% -2.6 -98% 22,094 1,185 472 285 -21,574 -20,902 54,436
Lexaria Bioscience (LXRP) 70,079 188% -16.2 -124% 3,457 132 97 183 -4,270 -4,215 68,083
Weed (BUDZ) 69,984 -2.1 -1,237% 2,651 619 0 0 -32,801 -32,618 69,980
George Risk (RSKIA) 69,554 49% 12.0 8% 44,046 3,542 14,248 6,956 3,532 5,311 63,887
American Resources (AREC) 68,466 49% -3.3 -42% 65,768 55,040 33,513 16,316 -27,405 -21,704 71,798
Easterly Acquisition (EACQ) 68,264 22.5 2% 146,697 10,863 0 0 3,039 3,039 68,262
Poage Bankshares (PBSK) 68,196 17.6 -1% 440,728 379,510 0 0 -2,208 2,582 45,344
Omnicomm Systems (OMCM) 67,280 82% 61.1 -6% 11,253 24,136 26,029 21,321 -694 1,177 71,940
Cyber Apps World (CETC) 67,162 -1,895.7 -3% 1,374 223 0 0 -35 -35 67,162
NutraFuels (NTFL) 66,807 54% -32.2 -42% 5,060 2,376 3,589 1,927 -2,109 -2,052 66,157
Terra Tech (TRTC) 66,554 55% -5.5 -23% 144,218 34,078 31,730 17,497 -33,504 -15,277 83,382
India Globalization Capital (IGC) 66,379 2% -10.2 -15% 33,505 1,085 5,287 131 -4,963 -4,898 49,825
MRI Interventions (MRIC) 65,694 66% -14.0 -41% 13,270 6,362 9,162 6,003 -5,417 -4,365 61,233

Balance Sheet ($'000)2011-10-312012-01-312012-10-312013-10-312015-08-312016-08-312017-08-312018-08-31
Cash3114018166260932,5331,727
Accounts Receivable231176291793113145266
Inventory1681356787
PP&E0221
Assets4,3394,2284,1923,5737125672,8602,432
Accounts Payable
Long-Term Debt
Liabilities1,6781,6761,7711,474554799244
Stockholders' Equity2,6612,5522,4212,0997722663,0062,388
Income Statement ($'000)2011-10-312012-01-312012-10-312013-10-312015-08-312016-08-312017-08-312018-08-31
Revenue154164433
Cost of Revenue66878379530463025
Gross Profit466574302-15-534408
R&D146954493
SG&A46615295197328707
Tax000000
Net Income-538-1,983-6,609
Cash Flow ($'000)2011-10-312012-01-312012-10-312013-10-312015-08-312016-08-312017-08-312018-08-31
Cash Operating-195136321-1,501-661-1,546-2,518
Cash Investing-698-274-71685-20-10-155
Cash Financing861288-3653735143,9961,867